Page 3 - இந்தியன் நிறுவனம் ஆஃப் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The ongoing second wave of Covid-19, in which number of children affected have seen a rise, has alerted the country s health experts to stress on ways to handle children, with pre-existing co-morbidities, who have been infected with the deadly virus. In India, 26 per cent of the population is less than 14 years of age and nearly seven per cent are less than five-years-old. Prof Sheffali Gulati, a Child neurologist at All Indian Institute of Medical Sciences (AIIMS) Delhi told ANI, What we are stressing at is how to handle the risk of children with pre-existing co-morbidities. Their risk stratification should be done because just like adults children are also not devoid of co-morbid conditions. There are children who are having a neurological problem or under long term medication for which they are given steroids. So we have to think in a different way for them.

Sheffali gulatiSisir paulNational commission for protection of child rightsIndian institute of medical sciencesEmergency transport serviceIndian council of medical researchAll indian instituteMedical sciencesNational commissionChild rightsDrugs controller generalBharat biotechIndian councilMedical researchMadhukar rainbow childrenCovid 19